Verapamil-d6

• Description :

  Verapamil-d6 ((±) -Verapamil-d6) is deuterium labeled Verapamil. Verapamil ((±) -Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].

• Product Name Alternative :

  (±) -Verapamil-d6; CP-16533-1-d6

• UNSPSC :

  12352005

• Target :

  Isotope-Labeled Compounds

• Related Pathways :

  Others

• Applications :

  Metabolism-protein/nucleotide metabolism

• Field of Research :

  Metabolic Disease; Cancer; Cardiovascular Disease

• Smiles :

  COC1=CC=C(C=C1OC)C(C(C([2H])([2H])[2H])C([2H])([2H])[2H])(CCCN(C)CCC2=CC=C(C(OC)=C2)OC)C#N

• Molecular Formula :

  C27H32D6N2O4

• Molecular Weight :

  460.64

• References & Citations :

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Isotope-Labeled Compounds

• Clinical Information :

  No Development Reported